Skip to content

Good night · 19 November, Thursday

9° Rain
USD 50.44 ▲0.05 EUR 55.34 ▼0.18 GBP 66.55 ▼0.11 CHF 60.06 ▼0.24
C CNBC · 3 h ago Follow Health

CEO turned informant: How the FDA built a case against executives promising cheap medications

The FDA's unprecedented criminal case against an alternative funding program hinged on the cooperation of a peer CEO, according to a court record.

This story comes from CNBC's feed; the full article and all rights belong to the source.

0

Report / takedown request

Your report is sent to our team and reviewed.

0

Comments (0)

No comments yet. Be the first to comment.

Sign in to write a comment.

Related news